Current Issue
Clinical
Careers
Services
Links
Contact Us
Benefits of Neupro on sleep and early movement in Parkinson’s disease
Written by IMN Monday, 08 March 2010 16:11
New data from the RECOVER study presented at the XVIII World Federation of Neurology World Congress on Parkinson’s Disease and Related Disorders in Miami Beach, Florida, showed that Neupro (rotigotine) was associated with clinically relevant and statistically significant improvements in sleep and early morning motor symptoms compared to placebo, UCB (Pharma) has announced.
Onbrez demonstrates 24-hr symptom control for COPD patients
Written by IMN Tuesday, 02 March 2010 12:40
Novartis has launched Onbrez (Indacaterol) as a new once-daily maintenance bronchodilator in adult patients with chronic obstructive pulmonary disease (COPD). This follows European approval, which was received in December (2009).
Long-term use of Vimpat supported
Written by IMN Tuesday, 02 March 2010 12:36
UCB (Pharma) has announced new findings on its antiepileptic drug (AED) Vimpat that offer additional clinical evidence supporting the use of this AED as adjunctive therapy in adult patients with partial-onset seizures.
Vista signs agreements with Quinn and Vhi
Written by IMN Tuesday, 02 March 2010 12:35
Vista Primary Care, Ireland’s leading primary healthcare campus for public and private patients, has announced that it has signed two new agreements to provide CT examinations to Quinn Healthcare members and MRI examinations to Vhi members.
“Milestone results” in RECOVER study
Written by IMN Friday, 12 February 2010 14:29
Boehringer Ingelheim has announced very positive results from their RE-COVER study – the most advanced trial programme assessing a novel oral anticoagulant in development for acute venous thrombo-embolism (VTE) treatment – presented at the American Society of Haematology annual meeting and published in the New England Journal of Medicine online.
More Articles...
Page 1 of 23